# Electromagnetic therapies (PEMF)

Rating: Early — Mostly animal or cell studies; few or uncontrolled human data
Type: Therapy
Updated: 2026-08-06
Canonical: https://heretic.bio/articles/electromagnetic-therapies.html

> Electromagnetic therapies span TENS, microcurrent, PEMF, and Rife. The proven core is PEMF, FDA-approved for non-union fractures since 1979 with growing evidence in osteoarthritis and post-surgical pain; microcurrent adds RCT support for wound healing. The contested fringe is frequency-specific and Rife-style claims, which the entry treats as unproven.

> **Core thesis:** Electromagnetic fields — when properly applied at specific frequencies and intensities — can non-invasively stimulate cellular healing, reduce pain, accelerate bone repair, and modulate inflammation. FDA-approved for non-union fractures since 1979, PEMF and related modalities have growing evidence for broader applications.

* * *

## Overview of Electromagnetic Modalities

Modality | Frequency Range | Mechanism | FDA Status  
---|---|---|---  
**PEMF** | 1-100 Hz | Pulsed field → cellular membrane signaling | Approved (bone healing)  
**TENS** | 1-250 Hz | Transcutaneous nerve stimulation → pain gate | OTC approved  
**Microcurrent (MENS)** | 0.1-1000 μA | Mimics endogenous current → ATP production | Research  
**PEMF High-intensity** | 1-50 Hz, high Gauss | Deep tissue penetration | Off-label  
**Frequency-specific microcurrent** | Specific frequency pairs | Tissue-specific resonance (contested) | Research  
**Rife therapy** | Specific RF frequencies | Pathogen destruction (unproven) | Not approved  
  
* * *

## Pulsed Electromagnetic Field Therapy (PEMF)

### Mechanism of Action

  1. **Faraday's law:** Changing magnetic fields induce electrical currents in conductive tissue
  2. **Cellular membrane effects:** Induced current modifies membrane potential → alters ion channel function
  3. **Calcium signaling:** PEMF increases intracellular Ca2+ → activates calmodulin → downstream healing cascades
  4. **ATP production:** Increased mitochondrial membrane potential → enhanced energy production
  5. **Growth factor release:** Stimulates VEGF, BMP-2, FGF release
  6. **Anti-inflammatory:** Modulates NF-κB signaling, reduces pro-inflammatory cytokines



### FDA-Approved Indications

  * **Non-union fractures** (since 1979) — strong evidence
  * **Post-operative edema and pain** (specific devices)
  * **Cervical fusion adjunct**



### Clinical Evidence

#### Bone Healing (Strong)

  * PEMF is FDA-approved for non-union fractures — one of the strongest evidence bases
  * Accelerates fracture healing by 30-40% in many studies
  * Stimulates osteoblast proliferation and differentiation
  * PMID: [PMC7434032](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434032/) — "PEMF is a safe and effective treatment for non-unions"



#### Osteoarthritis (Moderate)

  * **PMID[38610722](https://pubmed.ncbi.nlm.nih.gov/38610722/) (2024):** "PEMF demonstrated positive outcomes across various anatomical districts, primarily in knee osteoarthritis"
  * Reduces pain and improves function in knee OA
  * May have disease-modifying effects (cartilage preservation)



#### Soft Tissue Healing (Moderate)

  * PMID [19371845](https://pubmed.ncbi.nlm.nih.gov/19371845/) — "PEMF used successfully in management of postsurgical pain, chronic wounds, and vasodilation"
  * Accelerates wound healing, especially in diabetic patients
  * Reduces post-surgical pain and edema



#### Pain Management (Moderate)

  * Effective for chronic musculoskeletal pain
  * May reduce need for analgesic medications
  * Mechanism: endorphin release, nerve membrane stabilization



#### Neurological Applications (Emerging)

  * Depression: TMS (transcranial magnetic stimulation) is FDA-approved for treatment-resistant depression
  * Traumatic brain injury: Early research on PEMF for TBI recovery
  * Neuropathy: Some evidence for diabetic neuropathy symptom relief



### Uses

Parameter | Range in the literature | Notes  
---|---|---  
**Frequency** | 1-50 Hz | Different frequencies for different tissues  
**Intensity** | 1-50 Gauss (low-intensity) | Up to 2000 Gauss for high-intensity devices  
**Duration** | 20-60 min per session | Varies by condition  
**Treatment course** | 2-12 weeks | Bone healing: 3-6 months  
  
### Notable PEMF Devices

  * **OMPulse / MG-33:** Clinical-grade PEMF
  * **MAS PEMF:** High-intensity full-body systems
  * **Bemer:** Low-intensity, consumer-grade
  * **Ondamed:** Frequency-specific PEMF system
  * **Hugo:** High-intensity, affordable



* * *

## Transcutaneous Electrical Nerve Stimulation (TENS)

### Mechanism

  * **Gate control theory:** Non-painful electrical input closes the "gate" to painful input at spinal cord level
  * **Endorphin release:** High-frequency TENS triggers endogenous opioid release
  * **Does not heal tissue** — purely symptomatic pain relief



### Evidence

  * Moderate evidence for chronic musculoskeletal pain
  * Moderate evidence for neuropathic pain
  * Inconsistent evidence — responder vs. non-responder patterns
  * Best used as adjunct, not standalone



* * *

## Microcurrent Therapy (MENS) and FSM

See also: [Frequency-Specific Microcurrent](frequency-specific-microcurrent.html) for a full deep-dive.

### Mechanism

  * **Extremely low current** (microamperes) — usually below sensory threshold
  * Mimics or augments endogenous bioelectric currents involved in wound repair
  * May influence membrane potential, calcium flux, ATP demand, nitric oxide signaling, and local perfusion
  * **ATP/protein synthesis claims** usually trace to Cheng et al. (1982); useful mechanistic signal, but preclinical rather than proof of clinical efficacy
  * Promotes wound healing at cellular level when parameters and tissue context are appropriate



### Evidence

  * **Wound healing:** Moderate RCT/meta-analysis evidence. A 2022 meta-analysis of RCTs found greater wound area reduction and shorter healing time when electrical microcurrent was added to standard wound care (PMID [34903470](https://pubmed.ncbi.nlm.nih.gov/34903470/)).
  * **Palatal surgical wounds:** Double-masked RCT found faster closure/epithelialization and less early pain after free gingival graft harvest (PMID [32783220](https://pubmed.ncbi.nlm.nih.gov/32783220/)).
  * **Delayed-onset muscle soreness:** Small frequency-specific microcurrent RCT reported large reductions in post-eccentric-exercise soreness versus untreated control leg (PMID [20538225](https://pubmed.ncbi.nlm.nih.gov/20538225/)).
  * **FSM (Frequency-Specific Microcurrent):** Contested. Uses paired frequencies claimed to target tissue/pathology combinations. Pilot data and clinician reports are interesting, but the specific-frequency hypothesis remains less proven than generic microcurrent wound-healing effects.



### Practical Parameters

Parameter | Range in the literature | Notes  
---|---|---  
Current | ~10–1,000 μA | More is not necessarily better; often sub-sensory.  
Session length | 20–60 min | Acute DOMS study used 20 min; clinical FSM often longer.  
Delivery | electrodes, wet towels, graphite gloves | Skin contact and hydration affect current delivery.  
Best-supported use | wound-healing adjunct | Especially when objective wound size can be tracked.  
  
### Cautions

Avoid unsupervised use with implanted electrical devices, pregnancy over abdomen/pelvis, seizure history when treating near head/neck, or wounds/infections requiring medical care. Treat broad claims about curing chronic infections, cancer, or systemic disease as unproven until replicated in controlled trials.

* * *

## Critical Analysis

### What's Real

  * **PEMF for bone healing** is firmly established and FDA-approved
  * **PEMF for pain/inflammation** has growing evidence
  * **TENS for pain** is a reasonable non-pharmacological option
  * **Microcurrent** has biological plausibility and wound healing evidence



### What's Questionable

  * **Rife therapy:** Claims that specific RF frequencies destroy pathogens. No credible evidence. This borders on pseudoscience.
  * **Frequency-specific healing claims:** The idea that specific frequencies target specific tissues is not well-established
  * **Cancer treatment claims:** No evidence that electromagnetic therapies cure cancer
  * **Miracle cure marketing:** Many PEMF devices are marketed with exaggerated claims



### Why Conventional Medicine Resists

  * Electromagnetic therapy challenges the pharmaceutical paradigm
  * Insurance rarely covers these therapies
  * Medical education doesn't include bioelectromagnetics
  * The field has been polluted by pseudo-scientific marketing



* * *

## Practical Notes

### Conservative Selection Framework

  * **Bone non-union or fusion adjunct:** prioritize medically supervised PEMF with device parameters and orthopedic follow-up.
  * **Pain-only goal:** TENS may be sufficient and cheaper; do not infer structural healing from analgesia.
  * **Wound-healing adjunct:** microcurrent has a stronger evidence base than most “frequency medicine” claims; track wound area and healing time objectively.
  * **Soft tissue recovery:** consider PEMF, microcurrent, [Overview - Photobiomodulation](red-light-therapy.html), loading progression, and [Peptide Therapy for Injuries](peptide-therapy-for-injuries.html) as separate variables rather than adding everything at once.



### Safety Cautions

Avoid casual use over implanted electrical devices, pregnancy over abdomen/pelvis, active malignancy without oncology approval, open wounds unless the protocol/device is wound-specific, or infections requiring medical care. Device marketing often exceeds evidence; prefer published parameters and objective endpoints.

* * *

## Notes

  * PEMF has the strongest conventional/regulatory foothold in bone-healing applications.
  * Microcurrent has surprisingly decent wound-healing evidence but the exact clinical parameters remain heterogeneous.
  * FSM is promising enough to track but not mature enough to treat its frequency tables as established physiology.
  * Future expansion: split PEMF, TENS, microcurrent, and FSM into separate notes if this section becomes device/protocol-heavy.



* * *

## Sources

1. Shupak NM et al. (2003). "PEMF Stimulation of Bone Healing." PMC7434032 (PMC7434032)
2. further R et al. (2024). "Current Evidence Using PEMF." PMID 38610722 (PubMed 38610722)
3. Markov MS. (2015). "Evidence-Based Use of PEMF Therapy." PMID 19371845 (PubMed 19371845)
4. Poltawski L et al. (2022). "Electrical microcurrent stimulation therapy for wound healing: A meta-analysis of randomized clinical trials." PMID 34903470 . (PubMed 34903470)
5. PubMed 32783220 (PubMed 32783220)
6. Curtis D et al. (2010). "The efficacy of frequency specific microcurrent therapy on delayed onset muscle soreness." PMID 20538225 . (PubMed 20538225)